University of Florida Research Foundation Inc

Other

Ocean Spray Cranberries, Inc.

Susan S Percival

Christina Khoo

Clarence A Johnson

John St Cyr

Terri L Butler

DeAnn Liska

Gloria Cagampang

Robin J Henken

Andrew J Macintosh

Deann Liska

The present disclosure pertains to shortening blend compositions comprising a first oil, a second oil, and an emulsifier. The disclosed shortening blend compositions can comprise a first oil with an oleic acid content of about 50% or more and a saturated fatty acid content of about 35% or less; a second oil with an oleic acid content of about 75% or more and a saturated fatty acid content of about 20% or less; wherein the first oil and the second oil are derived from different sources; and an emulsifier. Also disclosed are methods of making the disclosed shortening blends and food products comprising a disclosed shortening blend. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Compositions and methods relating to shortening

Therapeutic use of extracts containing proanthocyanidin including treating disorders, e.g., inflammatory disorders, e.g., inflammatory bowel disease, Crohn's disease, ulcerative colitis, indeterminate colitis, microscopic colitis, collagenous colitis, and irritable bowel syndrome. Methods of increasing a subject's immunological resistance to an infection and/or treating the infection. The infection can be, e.g., a bacterial, viral, or fungal infection. The methods can include, e.g., selecting a subject that has, or is at risk of developing, an infection, e.g., a bacterial, viral, or fungal infection, or a combination thereof; providing a composition comprising at least about 10% proanthocyanidin by weight; and administering to the subject an amount of the composition to the subject, to thereby increase a subject's immunological resistance to an infection and/or to treat the infection.

Inflammation and immunity treatments

D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured ex vivo in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.

Compositions for enhancing the immune response

Growing community of inventors

Gainesville, FL, United States of America

Susan S Percival